The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?
-
Pfizer Trying To Overcome Patent Cliff – Courtesy (Seeking Alpha)
Pharma Live, , Intellectual Property Rights, 0
Pfizer Inc. (NYSE:PFE) is trying to overcome the patent cliff that has seen its recent quarter results suffer by...
-
RCEs and the New USPTO Patent Term Adjustment Rules – Courtesy (Global IP Matters)
Pharma Live, , Intellectual Property Rights, 0
On January 9, 2015, the Federal Register published final rules implementing changes to patent term adjustment (PTA) in view of Novartis v....
-
Patent Safe Harbor Applies To Supplemental New Drug Applications
Pharma Live, , Intellectual Property Rights, 0
POSTED BY JACOB D. MOORE AND COURTENAY C. BRINCKERHOFF ON 21 MAY 2015POSTED IN FEDERAL CIRCUIT DECISIONS;INFRINGEMENTOn May 13, 2015, the Federal Circuit confirmed...
-
The new drugs war – Courtesy (The Economists)
Pharma Live, , Intellectual Property Rights, 0
OF ALL the goods and services traded in the market economy, pharmaceuticals are perhaps the most contentious. Though produced...
-
Biogen Inc (BIIB) May Soon Trump Pfizer In Global CNS Drug Sales – Courtesy(bidnessetc.com)
Pharma Live, , Intellectual Property Rights, 0
Pfizer Inc. (NYSE:PFE), presently the world’s largest seller of central nervous system (CNS) drugs, may have its future lead...
-
Activists Urge Lawmakers to Prioritize Patients Over Patents – Courtesy(Jakarta Globe)
Pharma Live, , Intellectual Property Rights, 0
Jakarta. Public health activists have called on the government to review a number of key points included in a revised...
-
Amicus Briefs On Biosimilar Patent Litigation – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 23 APRIL 2015POSTED IN BIOSIMILARSAmgen has appealed the district court decision denying its motion for a...
-
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug ‘Stempeucel’ – Courtesy(Biospace)
Pharma Live, , Intellectual Property Rights, 0
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced...
![](https://ml7mn4k5dnn0.i.optimole.com/w:289/h:289/q:eco/f:best/https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)